Shore ND, De Giorgi U, Freedland SJ. Enzalutamide in Men With High-Risk Biochemically Recurrent Prostate Cancer: Rationale and Treatment Considerations From EMBARK. J Urol 2024 Sep 3:101097JU0000000000004228. doi: 10.1097/JU.0000000000004228.
PMID: 39226589